Mark A Marzinke

Associate Professor

20082019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2008 2019

2019

2-Hydroxypropyl-β-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis

Pons-Faudoa, F. P., Sizovs, A., Di Trani, N., Paez-Mayorga, J., Bruno, G., Rhudy, J., Manohar, M., Gwenden, K., Martini, C., Chua, C. Y. X., Varchi, G., Marzinke, M. A. & Grattoni, A., Jul 28 2019, In : Journal of Controlled Release. 306, p. 89-96 8 p.

Research output: Contribution to journalArticle

Cyclodextrins
Pharmacokinetics
HIV
Integrases
Injections

Incentives for Viral Suppression in People Living with HIV: A Randomized Clinical Trial

Silverman, K., Holtyn, A. F., Rodewald, A. M., Siliciano, R. F., Jarvis, B. P., Subramaniam, S., Leoutsakos, J. M., Getty, C. A., Ruhs, S., Marzinke, M. A. & Fingerhood, M., Jan 1 2019, In : AIDS and behavior.

Research output: Contribution to journalArticle

Viral Load
Motivation
Randomized Controlled Trials
HIV
Acquired Immunodeficiency Syndrome

Low Disclosure of PrEP Nonadherence and HIV-Risk Behaviors Associated With Poor HIV PrEP Adherence in the HPTN 067/ADAPT Study

Ojeda, V. D., Amico, K. R., Hughes, J. P., Wilson, E., Li, M., Holtz, T. H., Chitwarakorn, A., Grant, R. M., Dye, B. J., Bekker, L. G., Mannheimer, S., Marzinke, M. A. & Hendrix, C., Sep 1 2019, In : Journal of acquired immune deficiency syndromes (1999). 82, 1, p. 34-40 7 p.

Research output: Contribution to journalArticle

Disclosure
Risk-Taking
HIV
Tenofovir
Condoms

Pharmacokinetics of dapivirine transfer into blood plasma, breast milk, and cervicovaginal fluid of lactating women using the dapivirine vaginal ring

Noguchi, L. M., Hoesley, C., Kelly, C., Scheckter, R., Bunge, K., Nel, A., Marzinke, M. A., Hendrix, C., Dezzutti, C. S., Hillier, S. L., Bogen, D. L., Piper, J. M. & Beigi, R. H., Mar 1 2019, In : Antimicrobial agents and chemotherapy. e01930-18.

Research output: Contribution to journalArticle

Female Contraceptive Devices
Human Milk
Pharmacokinetics
Milk
Sexually Transmitted Diseases

Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women

Chen, B. A., Zhang, J., Gundacker, H. M., Hendrix, C., Hoesley, C. J., Salata, R. A., Dezzutti, C. S., Van Der Straten, A., Hall, W. B., Jacobson, C. E., Johnson, S., Mcgowan, I., Nel, A. M., Soto-Torres, L. & Marzinke, M. A., Mar 19 2019, In : Clinical Infectious Diseases. 68, 7, p. 1144-1151 8 p.

Research output: Contribution to journalArticle

Female Contraceptive Devices
Pharmacokinetics
Safety
Placebos
TMC120-R147681

Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamide

Cerrone, M., Alfarisi, O., Neary, M., Marzinke, M. A., Parsons, T. L., Owen, A., Maartens, G., Pozniak, A., Flexner, C. W. & Boffito, M., Jun 1 2019, In : The Journal of antimicrobial chemotherapy. 74, 6, p. 1670-1678 9 p.

Research output: Contribution to journalArticle

Tenofovir
Rifampin
Pharmacokinetics
GS-7340
Emtricitabine
Tenofovir
Hair
HIV
Alcohols
Education

Tenofovir disoproxil fumarate intravaginal ring for HIV pre-exposure prophylaxis in sexually active women: a phase 1, single-blind, randomised, controlled trial

Keller, M. J., Wood, L., Billingsley, J. M., Ray, L. L., Goymer, J., Sinclair, S., McGinn, A. P., Marzinke, M. A., Frank, B., Srinivasan, S., Liu, C., Atrio, J. M., Espinoza, L., Mugo, N., Spiegel, H. M. L., Anderson, P. L., Fredricks, D. N., Hendrix, C., Marrazzo, J., Bosinger, S. E. & 1 others, Herold, B. C., Aug 1 2019, In : The Lancet HIV. 6, 8, p. e498-e508

Research output: Contribution to journalArticle

Tenofovir
Randomized Controlled Trials
HIV
Ulcer
Placebos

Tenofovir Gel for Prevention of Herpes Simplex Virus Type 2 Acquisition: Findings From the VOICE Trial

VOICE Study Team, May 24 2019, In : The Journal of infectious diseases. 219, 12, p. 1940-1947 8 p.

Research output: Contribution to journalArticle

Tenofovir
Human Herpesvirus 2
Gels
Confidence Intervals
Sexual Behavior
Tenofovir
Eastern Africa
Pharmacokinetics
HIV
Population

The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM

McGowan, I., Wilkin, T., Landovitz, R. J., Wu, C., Chen, Y., Marzinke, M. A., Hendrix, C., Richardson, P., Eshleman, S., Andrade, A., Chege, W., Anderson, P. L., McCauley, M., Farley, J., Mayer, K. H., Anton, P., Brand, R. M., Cranston, R. D. & Gulick, R., Feb 1 2019, In : AIDS (London, England). 33, 2, p. 237-246 10 p.

Research output: Contribution to journalArticle

Tenofovir
Pharmacokinetics
Chemokine Receptors
Lymphoid Tissue
C Chemokines
Open Access
Tenofovir
Transgender Persons
Fumarates
Estrogens
HIV

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/ levonorgestrel vaginal rings

Thurman, A. R., Schwartz, J. L., Ravel, J., Gajer, P., Marzinke, M. A., Yousefieh, N., Anderson, S. M. & Doncel, G. F., May 1 2019, In : PloS one. 14, 5, e0217229.

Research output: Contribution to journalArticle

Open Access
Tenofovir
Female Contraceptive Devices
Levonorgestrel
Pharmacokinetics
Microbiota
2018
Tenofovir
Foams and Jellies Vaginal Creams
Pharmacokinetics
Gels
HIV

Daily and Nondaily Oral Preexposure Prophylaxis in Men and Transgender Women Who Have Sex with Men: The Human Immunodeficiency Virus Prevention Trials Network 067/ADAPT Study

Grant, R. M., Mannheimer, S., Hughes, J. P., Hirsch-Moverman, Y., Loquere, A., Chitwarakorn, A., Curlin, M. E., Li, M., Amico, K. R., Hendrix, C., Anderson, P. L., Dye, B. J., Marzinke, M. A., Piwowar-Manning, E., McKinstry, L., Elharrar, V., Stirratt, M., Rooney, J. F., Eshleman, S., McNicholl, J. M. & 2 others, Van Griensven, F. & Holtz, T. H., May 17 2018, In : Clinical Infectious Diseases. 66, 11, p. 1712-1721 10 p.

Research output: Contribution to journalArticle

Transgender Persons
HIV
Tablets
Protective Agents
Drug Monitoring

Development of rectal enema as microbicide (DREAM): Preclinical progressive selection of a tenofovir prodrug enema

Hoang, T., Date, A. A., Ortiz, J. O., Young, T. W., Bensouda, S., Xiao, P., Marzinke, M. A., Rohan, L., Fuchs, E., Hendrix, C., Gumber, S., Villinger, F., Cone, R. A., Hanes, J. S. & Ensign-Hodges, L., Jan 1 2018, (Accepted/In press) In : European Journal of Pharmaceutics and Biopharmaceutics.

Research output: Contribution to journalArticle

Tenofovir
Enema
Prodrugs
Anti-Infective Agents
Sexual Behavior

Elevated creatinine in a patient on IVIG-therapy

Knezevic, C. E., Ness, M. A., Kratz, L. E. & Marzinke, M. A., Nov 1 2018, In : Clinica Chimica Acta. 486, p. 94-97 4 p.

Research output: Contribution to journalArticle

Passive Immunization
Intravenous Immunoglobulins
Proline
Creatinine
Sarcosine Oxidase

FAME-04: A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of film and gel formulations of tenofovir

Bunge, K. E., Dezzutti, C. S., Hendrix, C., Marzinke, M. A., Spiegel, H. M. L., Moncla, B. J., Schwartz, J. L., Meyn, L. A., Richardson-Harman, N., Rohan, L. C. & Hillier, S. L., Aug 1 2018, In : Journal of the International AIDS Society. 21, 8, e25156.

Research output: Contribution to journalArticle

Tenofovir
Pharmacokinetics
Gels
Safety
Placebos

Fecal Coliform Bacterial Detection to Assess Enema Adherence in HIV Prevention Clinical Studies

Aung, W. S., Bakshi, R., Breakey, J., Johnson, J. E., Hendrix, C., Weld, E., Fuchs, E. & Marzinke, M. A., Jul 3 2018, (Accepted/In press) In : AIDS and Behavior. p. 1-7 7 p.

Research output: Contribution to journalArticle

Enema
HIV
Clinical Trials
Sensitivity and Specificity
Clinical Studies

Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples

Partners Demonstration Project Team, Jun 1 2018, In : AIDS and Behavior. 22, 6, p. 1758-1765 8 p.

Research output: Contribution to journalArticle

Fertility
HIV
Pregnancy
Therapeutics
Pregnancy Rate

Hypo-osmolar formulation of tenofovir (TFV) enema promotes uptake and metabolism of TFV in tissues, leading to prevention of SHIV/SIV infection

Xiao, P., Gumber, S., Marzinke, M. A., Date, A. A., Hoang, T., Hanes, J. S., Ensign-Hodges, L., Wang, L., Rohan, L., Fuchs, E., Hendrix, C. & Villinger, F., Jan 1 2018, In : Antimicrobial Agents and Chemotherapy. 62, 1, e01644-17.

Research output: Contribution to journalArticle

Tenofovir
Enema
Infection
Pharmacokinetics
Local Anti-Infective Agents

Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships

for the Partners Demonstration Project Team, Jul 13 2018, (Accepted/In press) In : AIDS and Behavior. p. 1-8 8 p.

Research output: Contribution to journalArticle

Risk-Taking
HIV
Uganda
Kenya
Population
Tenofovir
Glycerol
Pharmacokinetics
Gels
HIV

Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data

Rifat, D., Prideaux, B., Savic, R. M., Urbanowski, M. E., Parsons, T. L., Luna, B., Marzinke, M. A., Ordonez Suarez, A., DeMarco, V. P., Jain, S., Dartois, V., Bishai, W. R. & Dooley, K. E., Apr 4 2018, In : Science Translational Medicine. 10, 435, eaai7786.

Research output: Contribution to journalArticle

rifapentine
Rifampin
Tuberculosis
Pharmacokinetics
Clinical Trials

Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc

Vincent, K. L., Moss, J. A., Marzinke, M. A., Hendrix, C., Anton, P. A., Gunawardana, M., Dawson, L. N., Olive, T. J., Pyles, R. B. & Baum, M. M., Aug 1 2018, In : PLoS One. 13, 8, e0201952.

Research output: Contribution to journalArticle

Tenofovir
Anti-Retroviral Agents
Human immunodeficiency virus 1
pods
HIV-1

Predictors of Daily Adherence to HIV Pre-exposure Prophylaxis in Gay/Bisexual Men in the PRELUDE Demonstration Project

the PRELUDE Study Team & the NSW HIV Prevention Partnership Project, Jan 1 2018, (Accepted/In press) In : AIDS and Behavior.

Research output: Contribution to journalArticle

HIV
Blood Cells
Pharmaceutical Preparations
Protective Agents
South Australia

Pregnancy outcomes and infant growth among babies with in-utero exposure to tenofovir-based preexposure prophylaxis for HIV prevention

Partners Demonstration Project & Partners PrEP Study Teams M, Jan 1 2018, In : AIDS. 32, 12, p. 1707-1713 7 p.

Research output: Contribution to journalArticle

Tenofovir
Pregnancy Outcome
HIV
Pregnancy
Growth

Quality control practices for chemistry and immunochemistry in a cohort of 21 large academic medical centers

Rosenbaum, M. W., Flood, J. G., Melanson, S. E. F., Baumann, N. A., Marzinke, M. A., Rai, A. J., Hayden, J., Wu, A. H. B., Ladror, M., Lifshitz, M. S., Scott, M. G., Peck-Palmer, O. M., Bowen, R., Babic, N., Sobhani, K., Giacherio, D., Bocsi, G. T., Herman, D. S., Wang, P., Toffaletti, J. & 9 others, Handel, E., Kelly, K. A., Albeiroti, S., Wang, S., Zimmer, M., Driver, B., Yi, X., Wilburn, C. & Lewandrowski, K. B., Jul 3 2018, In : American Journal of Clinical Pathology. 150, 2, p. 96-104 9 p.

Research output: Contribution to journalArticle

Immunochemistry
Quality Control

Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women

Thurman, A. R., Schwartz, J. L., Brache, V., Clark, M. R., McCormick, T., Chandra, N., Marzinke, M. A., Stanczyk, F. Z., Dezzutti, C. S., Hillier, S. L., Herold, B. C., Fichorova, R., Asin, S. N., Rollenhagen, C., Weiner, D., Kiser, P. & Doncel, G. F., Jun 1 2018, In : PLoS One. 13, 6, e0199778.

Research output: Contribution to journalArticle

Tenofovir
Female Contraceptive Devices
Pharmacodynamics
cervical mucus
Levonorgestrel

Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial

Landovitz, R. J., Li, S., Grinsztejn, B., Dawood, H., Liu, A. Y., Magnus, M., Hosseinipour, M. C., Panchia, R., Cottle, L., Chau, G., Richardson, P., Marzinke, M. A., Hendrix, C., Eshleman, S., Zhang, Y., Tolley, E., Sugarman, J., Kofron, R., Adeyeye, A., Burns, D. & 6 others, Rinehart, A. R., Margolis, D., Spreen, W. R., Cohen, M. S., McCauley, M. & Eron, J. J., Nov 1 2018, In : PLoS Medicine. 15, 11, e1002690.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Pharmacokinetics
HIV
Safety
Injections

Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial

Vincent, K. L., Moss, J. A., Marzinke, M. A., Hendrix, C., Anton, P. A., Pyles, R. B., Guthrie, K. M., Dawson, L., Olive, T. J., Butkyavichene, I., Churchman, S. A., Cortez, J. M., Fanter, R., Gunawardana, M., Miller, C. S., Yang, F., Rosen, R. K., Vargas, S. E. & Baum, M. M., Sep 1 2018, In : PLoS Medicine. 15, 9, e1002655.

Research output: Contribution to journalArticle

Drug Compounding
Fumarates
HIV-1
Pharmacokinetics
Safety

Short Communication: Specimen Processing Impacts Tissue Tenofovir Pharmacokinetic Measurements

Bakshi, R., Breakey, J., Manohar, M., Jois, B., Fuchs, E. & Marzinke, M. A., Apr 1 2018, In : AIDS Research and Human Retroviruses. 34, 4, p. 354-356 3 p.

Research output: Contribution to journalArticle

Tenofovir
Pharmacokinetics
Biopsy
HIV
Pharmaceutical Preparations

Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial

Delany-Moretlwe, S., Lombard, C., Baron, D., Bekker, L. G., Nkala, B., Ahmed, K., Sebe, M., Brumskine, W., Nchabeleng, M., Palanee-Philips, T., Ntshangase, J., Sibiya, S., Smith, E., Panchia, R., Myer, L., Schwartz, J. L., Marzinke, M. A., Morris, L., Brown, E. R., Doncel, G. F. & 2 others, Gray, G. & Rees, H., Nov 1 2018, In : The Lancet Infectious Diseases. 18, 11, p. 1241-1250 10 p.

Research output: Contribution to journalArticle

Tenofovir
Foams and Jellies Vaginal Creams
South Africa
HIV Infections
HIV-1

Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis

Pyra, M., Anderson, P. L., Hendrix, C., Heffron, R., Mugwanya, K., Haberer, J. E., Thomas, K. K., Celum, C., Donnell, D., Marzinke, M. A., Bukusi, E. A., Mugo, N. R., Asiimwe, S., Katabira, E. & Baeten, J. M., Jan 1 2018, In : AIDS. 32, 13, p. 1891-1898 8 p.

Research output: Contribution to journalArticle

Tenofovir
HIV
Pregnancy
Pregnant Women
tenofovir diphosphate

Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis

Chua, C. Y. X., Jain, P., Ballerini, A., Bruno, G., Hood, R. L., Gupte, M., Gao, S., Di Trani, N., Susnjar, A., Shelton, K., Bushman, L. R., Folci, M., Filgueira, C. S., Marzinke, M. A., Anderson, P. L., Hu, M., Nehete, P., Arduino, R. C., Sastry, J. K. & Grattoni, A., Sep 28 2018, In : Journal of Controlled Release. 286, p. 315-325 11 p.

Research output: Contribution to journalArticle

HIV
Pharmaceutical Preparations
Drug Implants
Macaca mulatta
Developed Countries
Tenofovir
Prodrugs
Fumarates
Liquids
Assays
2017

Brief Participant-Centered Convergence Interviews Integrate Self-Reports, Product Returns, and Pharmacokinetic Results to Improve Adherence Measurement in MTN-017

on behalf of the MTN-017 Protocol Team, Oct 26 2017, (Accepted/In press) In : AIDS and Behavior. p. 1-10 10 p.

Research output: Contribution to journalArticle

Tenofovir
Self Report
Pharmacokinetics
Interviews
Counseling

Characterization of HIV seroconverters in a TDF/FTC PrEP study: HPTN 067/ADAPT

Sivay, M. V., Li, M., Piwowar-Manning, E., Zhang, Y., Hudelson, S. E., Marzinke, M. A., Amico, R. K., Redd, A., Hendrix, C., Anderson, P. L., Bokoch, K., Gail-Bekker, L., van Griensven, F., Mannheimer, S., Hughes, J. P., Grant, R. & Eshleman, S., Mar 22 2017, (Accepted/In press) In : Journal of Acquired Immune Deficiency Syndromes.

Research output: Contribution to journalArticle

HIV
Tenofovir
Random Allocation
Drug Resistance
HIV Infections

Comparison of Dapivirine Vaginal Gel and Film Formulation Pharmacokinetics and Pharmacodynamics (FAME 02B)

Robinson, J., Marzinke, M. A., Bakshi, R., Fuchs, E., Radebaugh, C. L., Aung, W., Spiegel, H. M. L., Coleman Fennell, J. S., Rohan, L. C. & Hendrix, C., Apr 1 2017, In : AIDS Research and Human Retroviruses. 33, 4, p. 339-346 8 p.

Research output: Contribution to journalArticle

Foams and Jellies Vaginal Creams
Pharmacokinetics
Gels
HIV
Tenofovir
virology
Virology
Human immunodeficiency virus 1
neutralization
Immunoglobulin A

Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): A randomised, open-label, phase 2 trial

Bekker, L. G., Roux, S., Sebastien, E., Yola, N., Amico, K. R., Hughes, J. P., Marzinke, M. A., Hendrix, C., Anderson, P. L., Elharrar, V., Stirratt, M., Rooney, J. F., Piwowar-Manning, E., Eshleman, S., McKinstry, L., Li, M., Dye, B. J. & Grant, R. M., 2017, (Accepted/In press) In : The Lancet HIV.

Research output: Contribution to journalArticle

Tenofovir
Pre-Exposure Prophylaxis
HIV
HIV Seropositivity
Intention to Treat Analysis

Dapivirine vaginal ring use does not diminish the effectiveness of hormonal contraception

Balkus, J. E., Palanee-Phillips, T., Reddy, K., Siva, S., Harkoo, I., Nakabiito, C., Kintu, K., Nair, G., Chappell, C., Kiweewa, F. M., Kabwigu, S., Naidoo, L., Jeenarain, N., Marzinke, M. A., Soto-Torres, L., Brown, E. R. & Baeten, J. M., May 23 2017, (Accepted/In press) In : Journal of Acquired Immune Deficiency Syndromes.

Research output: Contribution to journalArticle

Female Contraceptive Devices
Contraception
Pregnancy
HIV-1
Incidence

Depression and ART Initiation Among HIV Serodiscordant Couples in Kenya and Uganda

Partners Demonstration Project Team, Aug 1 2017, In : AIDS and Behavior. 21, 8, p. 2509-2518 10 p.

Research output: Contribution to journalArticle

Uganda
Kenya
HIV
Depression
Therapeutics

Effect of maternal obesity on Maternal-Fetal transfer of preoperative cefazolin at cesarean section

Groff, S. M., Fallatah, W., Yang, S., Murphy, J., Crutchfield, C., Marzinke, M. A., Kurtzberg, J., Lee, C. K., Burd, I. & Azadeh, F., May 1 2017, In : Journal of Pediatric Pharmacology and Therapeutics. 22, 3, p. 227-232 6 p.

Research output: Contribution to journalArticle

Cefazolin
Cesarean Section
Obesity
Mothers
Surgical Wound Infection

Evaluation of a multidrug assay for monitoring adherence to a regimen for HIV preexposure prophylaxis in a clinical study, HIV prevention trials network 073

Zhang, Y., Clarke, W., Marzinke, M. A., Piwowar-Manning, E., Beauchamp, G., Breaud, A., Hendrix, C., Cloherty, G. A., Emel, L., Rose, S., Hightow-Weidman, L., Siegel, M., Shoptaw, S., Fields, S. D., Wheeler, D. & Eshleman, S., Jul 1 2017, In : Antimicrobial Agents and Chemotherapy. 61, 7, e02743-16.

Research output: Contribution to journalArticle

Tenofovir
HIV
Pharmaceutical Preparations
Limit of Detection
Clinical Studies

High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women

Carballo-Diéguez, A., Balán, I. C., Brown, W., Giguere, R., Dolezal, C., Leu, C. S., Marzinke, M. A., Hendrix, C., Piper, J. M., Richardson, B. A., Grossman, C., Johnson, S., Gomez, K., Horn, S., Kunjara Na Ayudhya, R. P., Patterson, K., Jacobson, C., Bekker, L. G., Chariyalertsak, S., Chitwarakorn, A. & 8 others, Gonzales, P., Holtz, T. H., Liu, A., Mayer, K. H., Zorrilla, C., Lama, J., McGowan, I. & Cranston, R. D., Jul 1 2017, In : PLoS One. 12, 7, e0181607.

Research output: Contribution to journalArticle

Transgender Persons
Anti-Infective Agents
Tenofovir
mouth
disease control

Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial

for the MTN-020 ASPIRE Study Team, Jul 24 2017, (Accepted/In press) In : Journal of Acquired Immune Deficiency Syndromes.

Research output: Contribution to journalArticle

HIV-1
Placebos
Clinical Trials
Research Personnel
Pharmaceutical Preparations
HIV-1
Tenofovir
Licensure
Pre-Exposure Prophylaxis
Self Report

MTN-017: A rectal phase 2 extended safety and acceptability study of tenofovir reduced-glycerin 1% gel

Cranston, R. D., Lama, J. R., Richardson, B. A., Carballo-Diéguez, A., Na Ayudhya, R. P. K., Liu, K., Patterson, K. B., Leu, C. S., Galaska, B., Jacobson, C. E., Parikh, U. M., Marzinke, M. A., Hendrix, C., Johnson, S., Piper, J. M., Grossman, C., Ho, K. S., Lucas, J., Pickett, J., Bekker, L. G. & 10 others, Chariyalertsak, S., Chitwarakorn, A., Gonzales, P., Holtz, T. H., Liu, A. Y., Mayer, K. H., Zorrilla, C., Schwartz, J. L., Rooney, J. & McGowan, I., 2017, In : Clinical Infectious Diseases. 64, 5, p. 614-620 7 p.

Research output: Contribution to journalArticle

Tenofovir
Glycerol
Gels
Safety
Transgender Persons

Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque model

Smith, J. M., Moss, J. A., Srinivasan, P., Butkyavichene, I., Gunawardana, M., Fanter, R., Miller, C. S., Sanchez, D., Yang, F., Ellis, S., Zhang, J., Marzinke, M. A., Hendrix, C., Kapoor, A. & Baum, M. M., Oct 1 2017, In : PLoS One. 12, 10, e0185946.

Research output: Contribution to journalArticle

Pharmacokinetics
Macaca
pharmacokinetics
pods
estradiol